SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as traders debate whether the stock has reached a technical bottom or if its removal from the S&P 100 index signals further downside. While many retail traders express bearish sentiment and concerns over weak demand and competition, others view the current valuation as a contrarian opportunity for a long-term turnaround.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as investors debate the impact of disappointing DM1 drug trial results from a competitor, which has triggered volatility and speculation despite the potential for Sarepta to gain long-term strategic advantage. The community remains divided, with many traders viewing the current price weakness as a buying opportunity based on strong core revenues and an undervalued pipeline, while others express frustration over persistent share price underperformance and the lack of clarity on upcoming clinical data catalysts.

VeChain is a public Layer-1 blockchain designed for real-world applications. Founded in 2015, its VeChainThor network supports enterprise and consumer use cases involving supply chains, product provenance, sustainability, digital product passports, tokenized incentives and verifiable data.  VeChainThor combines EVM-compatible smart contracts with a dual-token model, native fee delegation and multi-clause transactions. VET is the network’s native asset and staking collateral, while VTHO is used to pay transaction fees and execute smart contracts.  VeChain’s ecosystem includes VeBetter, an app platform that rewards verified positive actions; StarGate, its NFT-based staking platform; VeWorld, its self-custody wallet; and VeWorld.ai, its AI-agent platform. In its April 2026 roadmap, VeChain reported that VeBetter had reached 5.3 million users, more than 50 live applications and over 50 million verified actions.  VeChain has also worked with organizations including Walmart China, DNV, PwC, Boston Consulting Group and UFC across enterprise, sustainability and consumer initiatives.

Vechain

VeChain is receiving significant attention as traders debate the project's long-term viability, with many expressing frustration over persistent price declines and the coin's weak performance relative to other assets. While some investors view the current low price as a buying opportunity, others are liquidating positions, citing poor communication and missed expectations regarding network adoption.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as investors discuss its role in the AI data center infrastructure theme and anticipation of potential partnership announcements, with strong community debate focused on the company's valuation, execution risks, and a high level of short interest that some believe may lead to a squeeze. Traders are monitoring technical resistance levels around the $40-$45 range, while competing viewpoints highlight concerns over share dilution and management compensation versus the long-term potential of the company's AI-focused business model.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending as traders speculate on the final outcome of the pending Hapag-Lloyd acquisition amid regulatory pushback, while simultaneously monitoring favorable shipping rate trends and dividend potential. Community sentiment remains divided between those prioritizing the deal's completion at the current offer price and those betting on a higher-value buyout or standalone upside.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

The community discussion remains fragmented, with traders divided between frustration over the price performance and long-term conviction in the network's technological utility. Bullish participants frequently highlight the project's decentralized infrastructure, AI integrations, and ongoing adoption efforts, while bears cite historical price declines and supply dynamics as primary concerns.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two Interactive is trending as investors react to a combination of persistent Grand Theft Auto VI leaks and volatility leading up to the game's highly anticipated extended preview. While retail sentiment shows signs of frustration over the leaks and the stock's recent correction, many traders remain bullish, viewing the dips as buying opportunities ahead of the scheduled November launch.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is trending as traders react to broad market volatility, rotational shifts out of software and hyperscalers into semiconductors, and ongoing speculation regarding Federal Reserve interest rate policy and geopolitical tensions in the Middle East.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing increased investor attention as the community anticipates commercial updates and potential order announcements throughout September. Traders are closely watching upcoming industry conferences, where the company is scheduled to present its Blazar light source and other optical engine technologies, while sentiment remains divided between those expecting a significant re-rating on production progress and skeptics questioning revenue conversion.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is trending due to persistent volatility in the offshore drilling sector and investor focus on the company's deleveraging progress alongside its $1 billion contract win with Equinor. While some traders view current price levels as a bargain based on long-term backlog and operational potential, others remain skeptical, citing concerns over merger arbitrage pressure and sector-wide headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are OGN, TBRG, CYCN Obtaining Fair Deals for their Shareholders?

Are OGN, TBRG, CYCN Obtaining Fair Deals for their Shareholders? Are OGN, TBRG, CYCN Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 4, 2026 Insiders may stand to receive...

Are UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Shareholders?

Are UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Shareholders? Are UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 9, 2026 Insiders may stand to...

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--CYCN, CECO, THR, and CWAN

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--CYCN, CECO, THR, and CWAN $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--CYCN, CECO, THR, and CWAN...

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN)

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of...

CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) and Korsana Biosciences, Inc. Upon closing of the proposed transaction...

Globalstar, Exxon Mobil, Cyclerion Therapeutics, Eli Lilly And Intel: Why These 5 Stocks Are On Investors' Radars Today

GSAT, XOM, CYCN, LLY, INTC were among the stocks seen trending on Wednesday, April 1, 2026.read more...

Shareholder Alert: Ademi LLP investigates whether Cyclerion Therapeutics Inc. is obtaining a Fair Price for Public Shareholders

Shareholder Alert: Ademi LLP investigates whether Cyclerion Therapeutics Inc. is obtaining a Fair Price for Public Shareholders Shareholder Alert: Ademi LLP investigates whether Cyclerion...

Promising Medical Stocks To Consider - April 1st

Eli Lilly and Company, Cyclerion Therapeutics, Apellis Pharmaceuticals, UnitedHealth Group, Novo Nordisk A/S, Boston Scientific, and Johnson & Johnson are the seven Medical stocks to watch today...

Best Pharmaceutical Stocks To Follow Now - April 1st

Eli Lilly and Company, Cyclerion Therapeutics, Apellis Pharmaceuticals, Novo Nordisk A/S, and Pfizer are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool...

Cyclerion Therapeutics Stock Soars 350% On Korsana Merger, $380 Million Financing

Cyclerion Therapeutics shares are trading sharply higher Wednesday morning after it announced a merger agreement with Korsana Biosciences.read more...

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.

Cyclerion Therapeutics Inc

CYCN Stock Is Soaring 274% Today — What Is Fueling The Rally?

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

CYCN Cyclerion Therapeutics Inc

Fundamentals

Latest CYCN News